Lung Cancer Screening “Cascade” Trials preliminary results.

Text generated by AI based on an exclusive interview, revised and reviewed by

Dr Jean-Philippe MINART, Cannes, France

January 23, 2025

Marie-Pierre REVEL, MD, PhD, Radiologist, Paris, France

Marie-Pierre REVEL, MD, PhD, Radiologist, Paris, France

What are the options in HER2 postive breast cancer treatments are we moving to t-DXd in first line?
Hassan GHAZAL
oncologist, Dubai
Biological and anatomo-pathological characteristics.
Kadria SAYED
What strategy to use to manage side effects in practice?
Georgia DEMETRIOU
oncologist, Johannesburg, SA
Qu’attendre de ce premier Breast Cancer Update ?
Jean-Philippe SPANO

Chairman of Oncology department , University hospital Pitié-Salpétrière, Paris, France
Genetic assessment and management in high-risk patients.
Pascal PUJOL